HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Figures Only Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Samady, H. Articles by Barringhaus, K. G. Search for Related Content PubMed PubMed Citation Articles by Samady, H. Articles by Barringhaus, K. G.

CLINICAL RESEARCH: MYOCARDIAL INFARCTION

Fractional Flow Reserve of Infarct-Related Arteries Identifies Reversible Defects on Noninvasive Myocardial Perfusion Imaging Early After Myocardial Infarction

Habib Samady, MD, FACC ^{_* , _*} , Wolfgang Lepper, MD, Eric R. Powers, MD, FACC, Kevin Wei, MD, FACC^{||, 1} , Michael Ragosta, MD, FACC _^* , Gregory G. Bishop, MD, Ian J. Sarembock, MD, FACC, Lawrence Gimple, MD, FACC, Denny D. Watson, PhD, George A. Beller, MD, MACC and Kurt G. Barringhaus, MD^¶

^_* Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia
University Hospital RWTH Aachen, Aachen, Germany
Cardiovascular Division, University of Virginia School of Medicine, Charlottesville, Virginia
Department of Radiology, University of Virginia School of Medicine, Charlottesville, Virginia
^|| Oregon Health and Science University, Portland, Oregon
^¶ Cardiovascular Division, University of Massachusetts Medical School, Worcester, Massachusetts

Manuscript received October 18, 2005; revised manuscript received January 5, 2006, accepted January 9, 2006.

^_* Reprint requests and correspondence: Dr. Habib Samady, Andreas Gruentzig Cardiovascular Center, Emory University School of Medicine, 1364 Clifton Road NE, Atlanta, Georgia 30322. (Email: hsamady{at}emory.edu).

	Abstract

Top Abstract Methods Results Discussion References

 
OBJECTIVES: We hypothesized that fractional flow reserve (FFR) of an infarct-related artery (IRA) early after myocardial infarction (MI) identifies inducible ischemia on noninvasive imaging.

BACKGROUND: Early after MI, IRAs frequently have angiographically indeterminant lesions. Whether FFR can detect reversible perfusion defects early after MI when dynamic microvascular abnormalities are present is not known.

METHODS: Rest and dipyridamole (DP)-stress ^99mTc sestamibi single-photon emission computed tomography (SPECT) were performed in 48 patients 3.7 ± 1.3 days after MI, with 23 patients undergoing concurrent myocardial contrast echocardiography (MCE). Angiography, FFR, and percutaneous coronary intervention (PCI) of the IRA (as necessary) were subsequently performed. Follow-up SPECT was performed 11 weeks after PCI to identify true reversibility on baseline SPECT.

RESULTS: The sensitivity, specificity, positive and negative predictive value, and concordance of FFR 0.75 for detecting reversibility on SPECT were 88%, 50%, 68%, 89%, and 71% (chi-square <0.001), respectively; which improved to 88%, 93%, 88%, 93%, and 91% (chi-square <0.001), respectively, for the detection of true reversibility. The corresponding values of FFR 0.75 for detecting reversibility on DP-MCE were 90%, 100%, 100%, 75%, and 93% (chi-square <0.001), respectively, and on either SPECT or MCE were 88%, 93%, 91%, 91%, and 91% (chi-square <0.001), respectively. The optimal FFR value for discriminating inducible ischemia on noninvasive imaging was 0.78.

CONCLUSIONS: Fractional flow reserve of the IRA accurately identifies reversibility on noninvasive imaging early after MI. These findings support the utility of FFR early after MI.

Abbreviations and Acronyms   DP = dipyridamole   DS = diameter stenosis   FFR = fractional flow reserve   IRA = infarct-related artery   MCE = myocardial contrast echocardiography   MI = myocardial infarction   NPV = negative predictive value   NS = not specified   PCI = percutaneous coronary intervention   PI = pulsing intervals   PPV = positive predictive value   QCA = quantitative coronary angiography   SDS = segmental difference score   SPECT = single-photon emission computed tomography   SRS = segmental rest score   SSS = segmental stress score   STEMI = ST-segment elevation myocardial infarction   TnI = troponin I

Fractional flow reserve (FFR) has been developed as an invasive physiologic index of lesion severity and, if validated in this setting, would allow combined anatomic and physiologic evaluation of IRAs to determine suitability for revascularization. Although a FFR 0.75 correlates well with noninvasive determinants of ischemia in normal myocardium and late after MI (6,7), it is not known whether FFR has utility early after MI, a period characterized by microvascular injury and increases in microvascular resistance as well as dynamic flow changes.

We hypothesized that a FFR 0.75 of the IRA early after stabilized MI will correlate with inducible ischemia on noninvasive imaging. Although dipyridamole (DP)-stress ^99mTc-sestamibi single-photon emission computed tomography (SPECT) is frequently used for early post-infarction risk stratification, it may underestimate reversibility early after MI. We therefore also compared FFR to DP myocardial contrast echocardiography (MCE), which offers better spatial resolution than SPECT.

	Methods

Top Abstract Methods Results Discussion References

 
Study population.   The Human Investigation Committee at the University of Virginia approved the protocol, and all patients consented to participate in the study. Patients referred for angiography two days after non–ST-segment elevation myocardial infarction (STEMI) and three days after STEMI were enrolled. The diagnosis of MI was supported by typical ischemic chest pain and/or a troponin I (TnI) 5 with electrocardiographic changes of ischemia. Exclusion criteria were: 1) prior MI within the infarction bed; 2) ongoing ischemia or hemodynamic instability; 3) prior bypass of the index artery; 4) contraindication to DP or FFR; 5) complex three-vessel or left main disease; or 6) occlusion of or inability to determine the IRA lesion.

Catheterization and angiography.   Biplane left ventriculography was performed in right and left anterior oblique views. The infarct risk area was identified by two blinded investigators and defined as the number of segments on ventriculography supplied by the culprit lesion divided by a total of 14 segments (corresponding to the SPECT program).

A single observer performed quantitative coronary angiography (QCA) offline using a computer-assisted program (DICOM, Heartlab Inc., Westerly, Rhode Island) as previously described (8). The luminal diameter proximal and distal to the stenosis (reference diameter) and minimal luminal diameter were determined for all lesions. The percent diameter stenosis (DS) was calculated as the ratio of the minimal luminal diameter to reference diameter.

Determination of FFR.   Following angiography, FFR was determined using a 0.014-inch sensor-tipped high-fidelity pressure wire (RADI Medical, Uppsala, Sweden) as previously described (8). Heparin (50 U/kg) was administered intravenously. Simultaneous distal coronary and aortic pressures were recorded at baseline and during hyperemia (induced by intracoronary adenosine-30 µg in the right coronary artery and 40 to 60 µg in the left coronary artery). The FFR was calculated as the ratio of the mean distal intracoronary pressure to mean aortic pressure at the time of peak hyperemia. The FFR measurements were repeated after percutaneous coronary intervention (PCI) in 37 of 43 patients.

Percutaneous intervention.   Percutaneous coronary intervention was performed at the discretion of the clinician and interventionalist. All patients received glycoprotein IIb/IIIa inhibitors and intracoronary stents.

Noninvasive imaging.   Protocol
Rest-DP stress ^99mTc-sestamibi SPECT and MCE were performed concurrently within 24 h of angiography and FFR determination. One hour after injection of 240 to 300 MBq of ^99mTc-sestamibi at rest, SPECT imaging was performed using a Picker Prism 3000 triple-headed gamma camera (Picker, Cleveland, Ohio), followed by resting MCE. Three hours later, 0.56 mg · kg^–1 of dipyridamole was administered over 4 min, followed by an intravenous injection of 750 to 900 MBq of ^99mTc-sestamibi. Immediately following the administration of ^99mTc-sestamibi, MCE was repeated. One hour later, stress SPECT images were obtained. Continuous monitoring of the electrocardiogram and vital signs were obtained during stress. Repeat rest-DP SPECT studies were performed three months following PCI.

^99mTc-sestamibi SPECT
Quantitative determination of segmental ^99mTc-sestamibi uptake was performed using the University of Virginia program (14 segments per patient) (9). Two observers interpreted SPECT studies. Discordant interpretations were resolved by consensus. Individual segments were classified as being normal or abnormal. Abnormal stress perfusion defects were further classified as mild or severe. The abnormal stress images were compared with corresponding rest images and considered reversible, partially reversible, or fixed based on improved tracer uptake at rest. The SPECT reversibility was defined as at least one reversible or partially reversible segment in the infarct risk area.

For semiquantitative analysis, a segmental stress score (SSS) was derived from the stress images by allocating normal segments a score of 0, mild defect a score of 2, and severe defects a score of 4. Segmental rest scores (SRS) were allocated as follows: fixed defects: SRS = SSS; normal rest perfusion: SRS = 0; partially reversible mild/moderate defects: SRS = 1; partially reversible severe defects: SRS = 2. Segmental difference score (SDS), a semiquantitative marker of reversibility, was defined as the numeric difference between the stress and rest scores.

True negative SPECT was defined as a normal or fixed defect when the initial stress images were paired with post-PCI rest images (in order to adjust for known early post-MI reduced rest tracer uptake rendering reversible defects fixed). True positive SPECT was defined as reversible SPECT images (utilizing post-PCI rest images) that became fixed or normal after revascularization.

To investigate the ability of FFR to detect noninvasive ischemia in different degrees on infarction, we divided 21 patients with true noninvasive ischemia on SPECT or MCE into three groups based on TnI level: TnI <10 ng/dl, small MI; TnI 10 to 100 ng/dl, moderate MI; TnI >100 ng/dl, large MI.

MCE
For MCE, Definity (Bristol-Myers Squibb Medical Imaging, Billerica, Massachusetts) was diluted in saline and infused (AS50, Baxter, Deerfield, Illinois) at 90 to 120 ml^h–1. Digital cine loops of regional function and myocardial perfusion were acquired from the apical four-, two- and three-chamber views using harmonic imaging and intermittent ultraharmonic imaging, respectively (Sonos 5500, Philips Ultrasound, Andover, Massachusetts). Ultrasound transmission was gated to end-systole. Imaging settings were held constant throughout the study. Contrast-enhanced images were obtained at pulsing intervals (PIs) of 300 ms to 8 s and acquired on a magneto-optical disk.

Rest and DP-stress studies were analyzed offline using side-by-side display by a single blinded observer. In the infarct bed (akinetic segments), normal resting flow was defined as complete myocardial opacification at a PI of <4 s (10). Perfusion defects at long pulsing intervals represented the no-reflow zone. Abnormal hyperemic flow was defined as incomplete myocardial opacification at a PI >1 to 2 s during stress. Myocardial contrast echocardiography perfusion was classified as normal if both resting and hyperemic flow were normal. Stress perfusion defects were classified as reversible or fixed using the same 14-segment model as SPECT.

Statistics.   Results are reported as mean ± SD unless otherwise indicated. Chi-square analysis was performed for comparison of binary variables. Comparisons between continuous variables were performed by Student t tests. A Pearson’s correlation was used to define a continuous relation between FFR and SPECT segmental difference score. The sensitivity, specificity, positive and negative predictive values, and diagnostic accuracy of FFR 0.75 for determining reversibility by SPECT and MCE were determined. The k statistic was used to investigate the concordance between FFR values and SPECT/MCE. Receiver-operator characteristics were calculated for FFR predicting reversibility by noninvasive testing. A p value <0.05 was considered significant.

	Results

Top Abstract Methods Results Discussion References

 
Patient enrollment.   Of 75 patients enrolled, 27 were excluded because of coronary anatomy requiring surgery, IRA occlusion, or inability to identify the IRA. The remaining 48 patients underwent baseline SPECT and FFR measurements and constituted the first FFR/SPECT analysis. Of these 48 patients, 43 underwent PCI and 37 post-PCI FFR. Five of 48 patients had fixed defects, non-critical coronary stenoses by QCA, and FFR >0.75 and were treated medically.

Follow-up SPECT was performed in 31 patients at a mean of 11 ± 9 weeks after PCI. Of these 31 patients, 24 had true positive and true negative SPECT. Post-PCI FFR was available in 21 of these patients. The second FFR/SPECT comparison consisted of 45 paired studies of baseline FFR with true positive/true negative SPECT or post-PCI FFR paired with delayed SPECT. In 23 patients who underwent MCE, baseline FFR was compared to MCE. Finally, because of lack of a perfect noninvasive gold standard, 55 FFR data points were compared to a combined noninvasive standard, defined positive if either MCE or true positive/true negative SPECT was reversible and negative if both tests were fixed. These 55 FFR data points consisted of 45 true positive/negative SPECT data (13 of which also had MCE data) and 10 patients with MCE without true positive/negative SPECT data.

Clinical parameters.   Table 1 shows the clinical characteristics of the 48 study patients. Seventy-three percent had STEMI and received thrombolytics. Peak TnI was 108 ± 120 ng/dl, and time from MI to catheterization was 3.7 ± 1.3 days. The MI risk area was 35 ± 13% of the myocardium. Mean DS of IRA was 75 ± 13%. Thirty-three percent had moderate (DS = 40% to 70%) lesions and 67% had DS 70%. Mean FFR was 0.65 ± 0.17. Post-PCI DS and FFR were 5.0 ± 7.6% and 0.94 ± 0.05, respectively.

An FFR 0.75 had a sensitivity of 88%, specificity of 50%, positive predictive value (PPV) of 68%, negative predictive value (NPV) of 79%, and concordance of 71% for predicting the presence of a reversible defect on SPECT.

Discordances between FFR and baseline SPECT were demonstrated in 14 patients. Among 3 of 14 patients with reversible SPECT and FFR >0.75, 1 had FFR 0.83 and DS 71%, underwent PCI, and follow-up SPECT remained reversible, suggesting that baseline SPECT was false positive. The second patient had FFR 0.78 and DS 77%, underwent PCI, and follow-up SPECT normalized, suggesting true positive baseline SPECT. The third patient had FFR 0.86, DS 53% with an ulcerated lesion, underwent PCI, with follow-up SPECT becoming fixed, suggesting true positive baseline SPECT.

Follow-up SPECT was performed in 8 of 11 patients with FFR 0.75 and fixed SPECT defects. Six of these eight patients were reclassified as reversible when stress SPECT was paired against delayed-rest SPECT, suggesting that the baseline SPECT was falsely negative. All five MCEs available in these six patients demonstrated reversible defects (Fig. 1).

View larger version (75K): [in this window] [in a new window]   Figure 1 (A) Baseline rest and dipyridamole (DP)-stress vertical long axis single-photon emission computed tomography (SPECT) images and 10-week follow-up rest images are shown from a patient with anterior myocardial infarction who received thrombolytic therapy. When DP stress is paired with initial rest images there is a fixed perfusion defect in the anteroapical wall. When DP stress in paired with the delayed rest images, SPECT is reclassified as reversible. (B) Rest and post-DP stress myocardial contrast echocardiography images from the apical four-chamber view of the same patient demonstrate an apical-lateral perfusion defect during DP that was not present at rest, indicating reversibility. (C) Angiogram of the patient showing an 84% lesion in the left anterior descending coronary artery. (D) Fractional flow reserve (FFR) tracings showing an FFR of 0.48. QCA = quantitative coronary angiography.

View larger version (21K): [in this window] [in a new window]   Figure 2 Concordance between FFR and SPECT (DP-stress paired with late rest imaging). Abbreviations as in Figure 1.

View larger version (24K): [in this window] [in a new window]   Figure 3 Concordance between FFR and MCE. Abbreviations as in Figure 1.

View larger version (26K): [in this window] [in a new window]   Figure 4 Concordance between FFR and combined noninvasive imaging. Abbreviations as in Figure 1.

View larger version (13K): [in this window] [in a new window]   Figure 5 Sensitivity and specificity curves of fractional flow reserve for detecting reversibility of combined noninvasive testing.

QCA and noninvasive imaging.   There was no significant difference in QCA in patients with reversible or fixed SPECT (76 ± 10% vs. 71 ± 13% p = NS), true reversible or fixed SPECT (75 ± 11% vs. 71 ± 12% p = NS), or reversible or fixed MCE (76 ± 1 2% vs. 68 ± 19%; p = NS).

	Discussion

Top Abstract Methods Results Discussion References

 
Our study demonstrates that in medically stabilized patients after MI with patent IRAs, FFR 0.75 has: 1) high sensitivity (88%), limited specificity (50%), and a 71% diagnostic accuracy for detecting reversibility on SPECT imaging, which improves to 88%, 93%, and 92%, respectively, when only true positive SPECT studies were considered; 2) high sensitivity (89%), specificity (100%), and diagnostic accuracy (91%) for detecting reversibility on MCE; and 3) high sensitivity (91%), specificity (93%), and diagnostic accuracy (92%) for detecting reversibility using a combined SPECT/MCE gold standard. An FFR 0.78 was found to provide optimal discriminatory power for detecting reversibility on SPECT or MCE, with no significant loss in sensitivity to detect ischemia in large infarct sizes.

Debate has arisen regarding the accuracy of FFR after MI, as FFR determination depends upon the assumption that vasodilator-mediated hyperemia achieves a state of minimal and constant coronary resistance (8,11,12). DeBruyne et al. (7) showed that FFR identified inducible ischemia on SPECT in patients 20 ± 27 days (range 6 to 570 days) after MI, specifically excluding patients with MIs within six days of FFR assessment. Therefore, to date, whether FFR assessment of an IRA early after infarction has diagnostic value has remained uncertain. In this setting, microvascular stunning and injury, thromboemboli, platelet plugging, coronary vasospasm, and endothelial dysfunction may diminish microvascular reactivity, necessary for both invasive and noninvasive physiologic testing. Several investigators have shown that myocardial flow reserve is reduced early following infarction and improves over time (13,14). Thus, the fidelity of all vasodilator-dependent physiologic studies may be affected early after MI, a time when many patients undergo risk stratification. However, we found approximately one-third of our patients to have angiographically indeterminate lesions early after MI, and we have previously shown that visual angiographic analysis frequently overestimates the hemodynamic significance of indeterminate lesions (15). Therefore, the finding that FFR correlates well with state-of-the-art noninvasive imaging suggests that it may be an acceptable alternative to noninvasive physiologic testing to evaluate moderate lesions early after MI.

We found a better correlation between FFR and MCE than between FFR and baseline SPECT in patients early after MI. This likely relates to underestimation of reversibility by SPECT imaging performed early after MI owing to falsely diminished rest tracer uptake in this time period (16–18). Our observation that the specificity of FFR 0.75 for detecting reversibility on SPECT increased from 50% to 93% when only true positive and negative SPECT studies were considered supports the notion. The mechanism for the underestimation of rest flow by tracer uptake early after MI is not known but may relate to the limited spatial resolution of SPECT (15 mm for SPECT vs. <1 mm for MCE) or the partial volume effect (19). Another reason for the better correlation between FFR and MCE is that these techniques both assess blood flow within the infarct bed, unlike SPECT, which provides an assessment of relative differences in blood flow between different vascular territories.

Study limitations.   Not all patients underwent baseline MCE and post-revascularization SPECT imaging. However, no significant differences in baseline characteristics, infarct location, or DS of IRA were noted between patients who underwent the full study protocol compared with those who did not.

Given reduction in early post-MI vasodilator reserve, it is possible that both FFR and noninvasive testing underestimate the hemodynamic significance of residual lesions in IRAs.

Patients with occluded IRAs and massive infarcts with hemodynamic instability were excluded from this study; therefore, the observed relationship between FFR and residual ischemia in the IRA does not apply to that subgroup of patients. However, ability of FFR to identify noninvasive ischemia should apply to most reperfused STEMI and non-STEMI, as we enrolled consecutive unselected patients in our study.

Conclusions.   Fractional flow reserve of the IRA accurately identifies reversibility on noninvasive imaging early after MI. These findings support the utility of FFR early after MI.

	Acknowledgments

 
The microbubble contrast agent was provided by Bristol-Myers Squibb Medical Imaging (North Billerica, Massachusetts), and the ultrasound equipment was provided by Philips Ultrasound (Andover, Massachusetts).

	Footnotes

 
This study was partially supported by research grants from Radi Medical Systems (Uppsala, Sweden) and Guidant Corporation (Indianapolis, Indiana).

¹ Dr. Wei was the recipient of a Mentored Clinical Scientist Development Award (K08-HL03909) from the National Institutes of Health.

	References

Top Abstract Methods Results Discussion References

 

1. Wackers FJT, Zaret BL. Risk stratification soon after acute infarction Circulation 1999;100:2040-2042.[Free Full Text]
2. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summarya report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 2003;108:1404-1418.[Free Full Text]
3. Brown KA, Heller GV, Landin RS, et al. Early dipyridamole ^99mTc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac eventscomparison with submaximal exercise imaging. Circulation 1999;100:2060-2066.[Abstract/Free Full Text]
4. Schweiger MJ, Cannon CP, Murphy SA, et al. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience) Am J Cardiol 2001;88:831-836.[CrossRef][ISI][Medline]
5. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 2001;344:1879-1887.[Abstract/Free Full Text]
6. Pijls NHJ, de Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses N Engl J Med 1996;334:1703-1708.[Abstract/Free Full Text]
7. de Bruyne B, Pijls NHJ, Bartunek J, et al. Fractional flow reserve in patients with prior myocardial infarction Circulation 2001;104:157-162.[Abstract/Free Full Text]
8. McClish JC, Ragosta M, Powers ER, et al. Effect of acute myocardial infarction on the utility of fractional flow reserve for the physiologic assessment of the severity of coronary artery narrowing Am J Cardiol 2004;93:1102-1106.[Medline]
9. Smith WH, Kastner RJ, Calnon DA, Segalla D, Beller GA, Watson DD. Quantitative gated single photon emission computed tomography imaginga counts-based method for display and measurement of regional and global ventricular systolic function. J Nucl Cardiol 1997;4:451-463.[CrossRef][ISI][Medline]
10. Wei K, Crouse L, Villanueva F, et al. Patients with normal resting function need only undergo stress myocardial contrast echocardiographic imaging for detection of coronary disease J Am Soc Echocardiogr 2002;15:498.
11. Tamita K, Akasaka T, Takagi T, et al. Effects of microvascular dysfunction on myocardial fractional flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction Cathet Cardiovasc Intervent 2002;57:452-459.[CrossRef][ISI][Medline]
12. Seo J. Early dipyridamole stress myocardial SPECT to detect residual stenosis of infarct related arterycomparison with coronary angiography and fractional flow reserve. Kor J Int Med 2003;17:7-13.
13. Uren NG, Crake T, Lefroy DC, et al. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction N Engl J Med 1994;331:222-227.[Abstract/Free Full Text]
14. Ragosta M, Powers ER, Samady H, et al. Relationship between extent of residual myocardial viability and coronary flow reserve in patients with recent myocardial infarction Am Heart J 2001;141:456-462.[CrossRef][Medline]
15. Fischer JJ, Samady H, McPherson JA, et al. Comparison between visual assessment and quantitative angiography versus fractional flow reserve for native coronary narrowings of moderate severity Am J Cardiol 2002;90:210-215.[CrossRef][ISI][Medline]
16. Galli M, Marcassa C, Bolli R, et al. Spontaneous delayed recovery of perfusion and contraction after the first 5 weeks after anterior infarction. Evidence for the presence of hibernating myocardium in the infarcted area Circulation 1994;90:1386-1397.[Abstract/Free Full Text]
17. Tanaka R, Nakamura T. Time course evaluation of myocardial perfusion after reperfusion therapy by ^99mTc-Tetrofosmin SPECT in patients with acute myocardial infarction J Nucl Med 2001;42:1351-1358.[Abstract/Free Full Text]
18. Voon WC, Chen YW, Hsu CC, et al. Q-wave regression after acute myocardial infarction assessed by Tl-201 myocardial perfusion SPECT J Nucl Cardiol 2004;11:165-170.[Medline]
19. Zaret BL, Beller GA. Nuclear Cardiology. State of the Art and Future Directions. 2nd edition. St. Louis, MO: Mosby, Inc; 1999.

This article has been cited by other articles:

				K. M. Marques, P. Knaapen, R. Boellaard, A. A. Lammertsma, N. Westerhof, and F. C. Visser Microvascular Function in Viable Myocardium After Chronic Infarction Does Not Influence Fractional Flow Reserve Measurements J. Nucl. Med., December 1, 2007; 48(12): 1987 - 1992. [Abstract] [Full Text] [PDF]

This Article Abstract Figures Only Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Samady, H. Articles by Barringhaus, K. G. Search for Related Content PubMed PubMed Citation Articles by Samady, H. Articles by Barringhaus, K. G.